Machine learning ensemble meets clinical practice: developing a real-world risk prediction model for metabolic syndrome using super learner and scorecard approaches.

INTRODUCTION

Metabolic syndrome (MetS) refers to a cluster of metabolic abnormalities that significantly increase the risk of developing cardiovascular diseases (CVDs). Traditional binary definitions of MetS fall short in capturing its severity spectrum, limiting personalized risk stratification.

OBJECTIVES

We aimed to develop a super learner model and multilevel risk scorecard to improve MetS risk prediction and support early cardiovascular risk identification.

METHODS

This study included a total of 460,256 health examination records from Zhejiang, China (2018-2023), with 344,925 used for model development and 115,331 used for external validation. A super learner model combining multiple machine learning algorithms was constructed to predict MetS risk. Key predictors identified through feature selection were used to develop a logistic regression-based MetS risk scorecard, stratifying individuals into five risk levels for practical and interpretable applications.

RESULTS

The super learner model achieved area under the receiver operating characteristics (AUCs) of 0.816 (95 % confidence interval [CI]: 0.814-0.817) and 0.810 (95 % CI: 0.808-0.813) in the development and external validation cohorts, respectively. The risk scorecard, which incorporates ten predictors, demonstrated comparable performance, with AUCs of 0.793 (95 % CI: 0.791-0.794) and 0.788 (95 % CI: 0.785-0.791) in the respective cohorts. Based on the risk scorecard, individuals were stratified into five categories: very low, low, normal, high, and very high risk levels.

CONCLUSION

The super learner model provides a highly accurate tool for MetS risk prediction, whereas the risk scorecard offers a practical and interpretable solution for clinical and personal use. These models enable precise risk assessment to guide prevention and improve outcomes.